HORMONE HEALTH · ADULT EDUCATION
Menopause & HRT conversation
Explore menopause symptoms, timing and safety questions before discussing treatment.
Evidence, method & limitations
Guideline-based questions with a custom non-validated symptom-impact summary; not an HRT eligibility score.
Published scales are distinguished from custom checklists. This website implementation has not been independently clinically validated or individually clinician-reviewed. Source organizations do not endorse this website.
HORMONE HEALTH · YOUR NEXT CONVERSATION
Feeling different?
Start with what you notice.
A guided check-in for men’s testosterone concerns and women’s perimenopause or menopause symptoms. One question at a time, with clear next steps.
The 0–15 symptom-impact total is a custom, non-validated summary of five answers. It cannot diagnose hormone deficiency, estimate treatment benefit, recommend a dose or tell you that HRT is safe.
Answers stay in this page, are not saved, and are not attached to appointment texts or lab requests. Reload or restart to clear them.
Evidence & scoring method
Each symptom is rated 0 (none), 1 (mild), 2 (moderate) or 3 (severe). We add the five ratings, without diagnostic cutoffs. Medical history and fertility answers guide the discussion; this tool does not recommend a lab package. The clinical guidance—not this custom score—is evidence-based. No endorsement by the source organizations is implied.
- Endocrine Society — testosterone diagnosis, testing and safety ↗
- NICE NG23 — menopause identification and management (updated April 2026) ↗
Sources checked September 10, 2026. Tool requires clinic review before use in clinical decision-making.
